Literature DB >> 7686922

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

D K Podolsky1, R Lobb, N King, C D Benjamin, B Pepinsky, P Sehgal, M deBeaumont.   

Abstract

Recent studies have demonstrated the induced expression of endothelial adhesion molecules including E-selectin (also called endothelial leukocyte adhesion molecule-1), vascular cell adhesion molecule and intercellular adhesion molecule in actively involved mucosa of patients with ulcerative colitis and Crohn's disease. Similar induction has been demonstrated in the colon of the Cotton-top tamarin (CTT), a New World primate that experiences a spontaneous acute and chronic colitis resembling ulcerative colitis. To assess the potential importance of leukocyte adhesion as a necessary step in acute colitis, the effect of parenteral mAb directed against adhesion molecules on CTT colitis was evaluated in placebo-controlled blinded trials. Serial administration of either of two anti-E-selectin mAb designated BB11 and EH8 effectively coated endothelial surfaces expressing this vascular adhesion molecule. Although colitis activity was slightly diminished after the 10-d treatment period in CTT receiving either BB11 or EH8, this reduction was not significantly different than that seen in animals given a placebo control when assessed by a previously validated standardized scale of inflammatory activity: mean histologic activity grade 2.2 +/- 0.2 pretreatment vs 1.5 +/- 0.5 posttreatment in group receiving mAb and 2.1 +/- 0.1 pretreatment vs 1.3 +/- 0.5 posttreatment in the placebo group (P > 0.2). In contrast, administration of an anti-alpha 4 integrin mAb designated HP1/2 that binds VLA4 (alpha 4 beta 1) and presumably alpha 4 beta 7 integrins resulted in significant attenuation of acute colitis when compared to both pretreatment activity index (P = 0.005) and the placebo control group (P < 0.01): mean histologic activity grade 1.6 +/- 0.3 pretreatment vs 0.2 +/- 0.1 posttreatment in the group receiving HP1/2 and 1.8 +/- 0.5 pretreatment and 1.2 +/- 0.2 posttreatment in the placebo control group. These studies using a model of spontaneous colitis in the CTT demonstrate the feasibility of modulation of leukocyte-vascular adhesion and/or other integrin-mediated events possibly including T cell aggregation and T cell-stromal interactions, as well as lymphocyte homing. These results suggest both that these processes are important and possibly essential elements in sustaining acute colitis and that their disruption may result in therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686922      PMCID: PMC293619          DOI: 10.1172/JCI116575

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  Adhesive recognition sequences.

Authors:  K M Yamada
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  Activation-independent binding of human memory T cells to adhesion molecule ELAM-1.

Authors:  Y Shimizu; S Shaw; N Graber; T V Gopal; K J Horgan; G A Van Seventer; W Newman
Journal:  Nature       Date:  1991-02-28       Impact factor: 49.962

3.  Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1.

Authors:  R Lobb; G Chi-Rosso; D Leone; M Rosa; B Newman; S Luhowskyj; L Osborn; S Schiffer; C Benjamin; I Dougas
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

4.  Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1.

Authors:  R R Lobb; G Chi-Rosso; D R Leone; M D Rosa; S Bixler; B M Newman; S Luhowskyj; C D Benjamin; I G Dougas; S E Goelz
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

5.  Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

Authors:  K F Montgomery; L Osborn; C Hession; R Tizard; D Goff; C Vassallo; P I Tarr; K Bomsztyk; R Lobb; J M Harlan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1.

Authors:  E L Berg; M K Robinson; O Mansson; E C Butcher; J L Magnani
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

7.  Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence.

Authors:  J L Wallace; A Higa; G W McKnight; D E MacIntyre
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

8.  Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions.

Authors:  Y Shimizu; W Newman; T V Gopal; K J Horgan; N Graber; L D Beall; G A van Seventer; S Shaw
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

9.  Molecular mapping of functional domains of the leukocyte receptor for endothelium, LAM-1.

Authors:  G S Kansas; O Spertini; L M Stoolman; T F Tedder
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

10.  Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor.

Authors:  Y Imai; M S Singer; C Fennie; L A Lasky; S D Rosen
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more
  68 in total

Review 1.  Molecules controlling lymphocyte migration to the gut.

Authors:  M Salmi; S Jalkanen
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonists.

Authors:  Juswinder Singh; Herman van Vlijmen; Wen-Chemg Lee; Yusheng Liao; Ko-Chung Lin; Humayun Ateeq; Julio Cuervo; Craig Zimmerman; Charles Hammond; Michael Karpusas; Rex Palmer; Tapan Chattopadhyay; Steven P Adams
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

Review 3.  Alpha 4 integrin blockade in inflammatory bowel disease.

Authors:  S Ghosh
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 4.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

Review 5.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery.

Authors:  Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

7.  Anti-adhesion molecule therapy for inflammatory bowel disease.

Authors:  Subrata Ghosh; Remo Panaccione
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

8.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

Authors:  P E Watkins; B F Warren; S Stephens; P Ward; R Foulkes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 9.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

10.  Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Authors:  Shin-ichiro Takeda; Toru Sato; Tatsuro Katsuno; Tomoo Nakagawa; Yoshiko Noguchi; Osamu Yokosuka; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-11-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.